Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
$ 51.83MMarket Capitalization
VS
Market
Sector
Industry
History
$ 4.48Close
$ 2.05 - $ 8.48 52-Week Range
Ticker Information
Ticker
ADVMCompany Name
ADVERUM BIOTECHNOLOGIES INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQADVERUM BIOTECHNOLOGIES INC - Market Capitalization Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ADVM - Market Cap Historical data
| Date | Market Capitalization | Share Price (Adjusted Close) | Share Factor | Shares (Basic) |
|---|---|---|---|---|
| 6/30/2025 | $ 51.83M | $ 2.47 | 1 | 20.98M |
| 3/31/2025 | $ 43.03M | $ 2.06 | 1 | 20.89M |
| 12/31/2024 | $ 67.48M | $ 3.23 | 1 | 20.89M |
| 9/30/2024 | $ 156.85M | $ 7.54 | 1 | 20.8M |
| 6/30/2024 | $ 135M | $ 6.49 | 1 | 20.8M |
| 3/31/2024 | $ 199.47M | $ 9.61 | 1 | 20.76M |
| 12/31/2023 | $ 367.36M | $ 17.7 | 1 | 20.75M |
| 9/30/2023 | $ 91.93M | $ 9.1 | 1 | 10.1M |
| 6/30/2023 | $ 184.82M | $ 18.3 | 1 | 10.1M |
| 3/31/2023 | $ 84.48M | $ 8.4 | 1 | 10.06M |
Key Performance Insights, Last 5 Years
- ADVERUM BIOTECHNOLOGIES INC's latest trailing twelve months (TTM) Market Cap stands at $ 1.19B.
- Over the past 5 years, ADVERUM BIOTECHNOLOGIES INC's average Market Cap has been $ 260.81M.
- The median Market Cap for ADVERUM BIOTECHNOLOGIES INC during this period was $ 143.63M
- ADVERUM BIOTECHNOLOGIES INC reached its highest Market Cap over the past 5 years at $ 1.3B.
- The lowest Market Cap recorded by ADVERUM BIOTECHNOLOGIES INC in the same timeframe $ 43.03M
ADVERUM BIOTECHNOLOGIES INC's Market Cap vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Market Cap Benchmarks
Similar metrics to Shares:
- Share Factor - [Entity] Share factor is a multiplicant in the calculation of [MarketCap] and is used to adjust for: American Depository Receipts (ADRs) that represent more or less than 1 underlying share, and, companies which have different earnings share for different share classes (eg Berkshire Hathaway - BRK.B).
- Shares (Basic) - [Entity] The number of shares or other units outstanding of the entity's capital or common stock or other ownership interests; as stated on the cover of related periodic report (10-K/10-Q), after adjustment for stock splits.
- Free Cash Flow per Share - [Calculation] The amount of Free Cash Flow attributed to each share, calculated as [FCF] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- EBIT per Share - [Calculation] The amount of earnings before interest and taxes attributed to each share, calculated as [EBIT] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
- Operating Cash Flow per Share - [Calculation] The amount of Operating Cash Flow attributed to each share, calculated as [NCFO] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
Definition of Market Capitalization
[Calculation] Market Capitalization, also known as market cap, represents the value of all shares of a company. It is the product of the [SharesBas], share [Price] and [ShareFactor]. We use the adjusted close price as per filing date.Shares * Price * Share Factor
(=) Market Cap Market Cap for ADVERUM BIOTECHNOLOGIES INC is calculated as follows: Shares [ 9.75M ] * Price [ $ 121.8 ] * Share Factor [ 1 ]
(=) Market Cap [ $ 1.19B ] ADVM - Market Capitalization, Last 5 years
$ 43.03M
Minimum
Mar 31, 2025
$ 1.3B
Maximum
Dec 31, 2020
$ 260.81M
Average
$ 143.63M
Median
Market Cap Benchmark AnalysisMarket
The chart above depicts the distribution of Market Cap for companies in the Total Stock Market. The average Market Cap of the companies is $ 883.07M with a standard deviation of $ 1.16B.
The following table provides additional summary stats:
Market Cap in the Market:
| filtered constituents | 3.31K |
|---|---|
| min | $ 0 |
| max | $ 4.75B |
| average | $ 883.07M |
| median | $ 344.7M |
| std | $ 1.16B |